Literature DB >> 20358195

Key role of nuclear medicine in seeking biomarkers of Huntington's disease.

Ferdinando Squitieri, Andrea Ciarmiello.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20358195     DOI： 10.1007/s00259-010-1439-8

Source DB:  PubMed          Journal:  Eur J Nucl Med Mol Imaging        ISSN： 1619-7070            Impact factor:   9.236


× No keyword cloud information.
  36 in total

1.  Reversal of neuropathology and motor dysfunction in a conditional model of Huntington's disease.

Authors:  A Yamamoto; J J Lucas; R Hen
Journal:  Cell       Date:  2000-03-31       Impact factor: 41.582

2.  Functional brain changes in presymptomatic Huntington's disease.

Authors:  Sarah A J Reading; Adam C Dziorny; Laura A Peroutka; Mathew Schreiber; Lisa M Gourley; Venu Yallapragada; Adam Rosenblatt; Russell L Margolis; James J Pekar; Godfrey D Pearlson; Elizabeth Aylward; Jason Brandt; Susan S Bassett; Christopher A Ross
Journal:  Ann Neurol       Date:  2004-06       Impact factor: 10.422

3.  Huntington's disease in Venezuela: 7 years of follow-up on symptomatic and asymptomatic individuals.

Authors:  J B Penney; A B Young; I Shoulson; S Starosta-Rubenstein; S R Snodgrass; J Sanchez-Ramos; M Ramos-Arroyo; F Gomez; G Penchaszadeh; J Alvir
Journal:  Mov Disord       Date:  1990       Impact factor: 10.338

4.  Huntington disease: pathogenesis, biomarkers, and approaches to experimental therapeutics.

Authors:  Christopher A Ross; Ira Shoulson
Journal:  Parkinsonism Relat Disord       Date:  2009-12       Impact factor: 4.891

5.  Abnormal morphology of peripheral cell tissues from patients with Huntington disease.

Authors:  Ferdinando Squitieri; Alessandra Falleni; Milena Cannella; Sara Orobello; Federica Fulceri; Paola Lenzi; Francesco Fornai
Journal:  J Neural Transm (Vienna)       Date:  2009-10-16       Impact factor: 3.575

6.  Thalamic metabolism and symptom onset in preclinical Huntington's disease.

Authors:  A Feigin; C Tang; Y Ma; P Mattis; D Zgaljardic; M Guttman; J S Paulsen; V Dhawan; D Eidelberg
Journal:  Brain       Date:  2007-09-24       Impact factor: 13.501

7.  A new model for prediction of the age of onset and penetrance for Huntington's disease based on CAG length.

Authors:  D R Langbehn; R R Brinkman; D Falush; J S Paulsen; M R Hayden
Journal:  Clin Genet       Date:  2004-04       Impact factor: 4.438

8.  Impaired PGC-1alpha function in muscle in Huntington's disease.

Authors:  Rajnish K Chaturvedi; Peter Adhihetty; Shubha Shukla; Thomas Hennessy; Noel Calingasan; Lichuan Yang; Anatoly Starkov; Mahmoud Kiaei; Milena Cannella; Jenny Sassone; Andrea Ciammola; Fernando Squitieri; M Flint Beal
Journal:  Hum Mol Genet       Date:  2009-05-21       Impact factor: 6.150

9.  Loss of huntingtin-mediated BDNF gene transcription in Huntington's disease.

Authors:  C Zuccato; A Ciammola; D Rigamonti; B R Leavitt; D Goffredo; L Conti; M E MacDonald; R M Friedlander; V Silani; M R Hayden; T Timmusk; S Sipione; E Cattaneo
Journal:  Science       Date:  2001-06-14       Impact factor: 47.728

10.  The platelet maximum number of A2A-receptor binding sites (Bmax) linearly correlates with age at onset and CAG repeat expansion in Huntington's disease patients with predominant chorea.

Authors:  Vittorio Maglione; Milena Cannella; Tiziana Martino; Antonio De Blasi; Luigi Frati; Ferdinando Squitieri
Journal:  Neurosci Lett       Date:  2005-10-10       Impact factor: 3.046
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.